Dr. Howard D. Edington, MD

Dr. Edington practices at Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health.

Dr. Edington's NPI, 1568435592, was assigned on February 9, 2006. Dr. Edington graduated from Temple University School of Medicine in 1981. Dr. Edington holds Pennsylvania license MD027758E.

Dr. Edington's primary practice is Allegheny General Hospital, at 320 East North Avenue, Pittsburgh, PA 15212 in Allegheny County. The practice phone is (412) 359-3131.

Dr. Edington's primary practice is Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. Dr. Edington is also affiliated with West Penn Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Dr. Edington to 3 more hospitals, 1 breast imaging center, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Edington practices, 8 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Edington's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Edington is licensed in Pennsylvania.

CMS data shows 477 Medicare services from Dr. Edington across 9 procedure codes in 2024, for 264 Medicare patients. Medicare paid $51,731 for them.

CMS counts 264 Medicare patients who saw Dr. Edington in 2024. The largest group is 65 to 74, with 142 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Edington's median patient age at 73, with 44% women.

In 2024, Dr. Edington wrote 294 Medicare Part D claims for 143 patients. 100% of them were for generic drugs. CMS names the drug for 257 of them, across 4 drugs with 11 or more claims each, at $1,147 in total drug cost. In 2023, CMS named 223 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Edington for performance year 2024, reported through an alternative payment model (APM). Dr. Edington accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 68 procedures of melanoma (skin cancer) excision by Dr. Edington, more than 89% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Edington, published from 2014 to 2020. 2019 was the busiest year, with 2. The most frequent topics are Melanoma, Cancer Vaccines and Dendritic Cells. Dr. Edington's most frequent co-authors are David Lawrence Bartlett, MD, Larisa Greenberg, MD and Christie J. Hilton, DO.

CMS Open Payments shows 42 general payments to Dr. Edington from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Merck Sharp & Dohme Corporation paid the most, $9,348.

Dr. Edington graduated from Temple University School of Medicine in 1981.